A nurse is reviewing the medication profile of a patient who has been prescribed phenazopyridine for urinary tract infection (UTI) symptoms. Which of the following statements should the nurse include in the patient education?

A. "You may experience increased urinary frequency while on this medication.": Phenazopyridine does not cause increased urinary frequency. It acts as a local anesthetic on the urinary tract to relieve discomfort but has no diuretic effect on bladder function. B. "Take this medication for at least 10 days, even if your symptoms improve.": Phenazopyridine is typically prescribed for short-term use (usually no more than 2 days) to relieve UTI symptoms. Prolonged use is not recommended due to potential toxicity. C. "You should avoid wearing soft contact lenses while taking this medication.": Phenazopyridine may discolor body fluids, including tears, and can permanently stain soft contact lenses. Patients should be advised to avoid their use while on the drug. D. "This medication will treat the infection causing your symptoms.": Phenazopyridine does not have antibacterial properties. It only provides symptom relief from burning and urgency; the actual infection must be treated with antibiotics.